1492 Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $332K | Hold |
|
|||||
|
2025
Q2 | $213K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.01M | Sell |
|
|||||
|
2018
Q4 | $1.2M | Sell |
|
|||||
|
2018
Q3 | $2.61M | Sell |
|
|||||
|
2018
Q2 | $1.98M | Sell |
|
|||||
|
2018
Q1 | $1.6M | Hold |
|
|||||
|
2017
Q4 | $1.33M | Sell |
|
|||||
|
2017
Q3 | $1.33M | Sell |
|
|||||
|
2017
Q2 | $1.19M | Sell |
|
|||||
|
2017
Q1 | $1.06M | Hold |
|
|||||
|
2016
Q4 | $1.02M | Sell |
|
|||||
|
2016
Q3 | $2.5M | Buy |
|
|||||
|
2016
Q2 | $543K | Sell |
|
|||||
|
2016
Q1 | $537K | Sell |
|
|||||
|
2015
Q4 | $563K | Sell |
|
|||||
|
2015
Q3 | $485K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $4.56M | Buy |
|
|||||
|
2014
Q4 | $1.17M | Sell |
|
|||||
|
2014
Q3 | $1.05M | Sell |
|
|||||
|
2014
Q2 | $1.56M | Sell |
|
|||||
|
2014
Q1 | $1.73M | Buy |
|
|||||
|
2013
Q4 | $1.22M | Buy |
|